Ability to demonstrate awareness of Noonan syndrome | | | | | |
Ability to explain the clinical burden of Noonan syndrome and related disorders in the untreated state | | | | | |
Apply Sanger and genetic sequencing in the early diagnosis of Noonan syndrome | | | | | |
Ability to interpret clinical trial data and evidence (from outside of Europe) showing the impact of growth hormone therapy on improvement in clinical outcomes in short stature in patients diagnosed with Noonan syndrome | | | | | |